News

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...
CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...
Participants in a new study who used GLP-1 drugs had a much lower cancer risk than those who had bariatric surgery.
Wellcare, which offers Medicare Advantage and Medicare ... Medicare covers Zepbound for that purpose. It does not cover it solely for weight loss. Patients paying the list price for the ...
Larger studies are needed to confirm the findings, which offer the latest evidence that the medicines can do much more than ...
Health retailer The Vitamin Shoppe has seen a spike in demand for supplements that could help with loss of appetite, ...
Looking for undervalued stocks? Check out three top undervalued stocks to buy now in May, 2025 to boost your portfolio.